21 CFR § 1114.25 Premarket Tobacco Product Applications

§ 1114.25 Communication between FDA and applicants.

Current through Sep 8, 2026 · Read all of Part 1114

⚠ 2 pending changes to Part 1114

During the course of reviewing an application, FDA may communicate with an applicant about relevant matters, including scientific, medical, and procedural issues that arise during the review process and inspections. These communications may take the form of telephone conversations, letters, electronic communications, or meetings, and will be documented in the administrative file in accordance with § 10.65 of this chapter.

← § 1114.17 Resubmissions.§ 1114.27 Review procedure. →